World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
38769
World Ranking
8551
National Ranking
4402

John D. Shaughnessy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John D. Shaughnessy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 447 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John D. Shaughnessy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Shaughnessy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2019 - Fellow of the American Statistical Association (ASA)

Overview

John D. Shaughnessy is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research focuses primarily on medicine with contributions to biochemistry, genetics, and molecular biology. They have substantial work in hematology, oncology, molecular biology, immunology, and pathology and forensic medicine.

The scientist's research has a strong emphasis on multiple myeloma, reflected in their extensive publication record. Key topics covered include:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Cancer Treatment and Pharmacology
  • CAR-T cell therapy research
  • Chemokine receptors and signaling
  • Ubiquitin and proteasome pathways

Prominent publication venues where John D. Shaughnessy has contributed include:

  • Blood
  • Blood Advances
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Investigation
  • Cancers

Frequent co-authors collaborating with the scientist include:

  • Frits van Rhee
  • Maurizio Zangari
  • Carolina Schinke
  • Sharmilan Thanendrarajan
  • Samer Al Hadidi

Selected recent papers by John D. Shaughnessy demonstrate a focus on multiple myeloma biology, therapy, and disease progression:

  • Risks of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis, 2023, Blood Advances
  • TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies, 2021, Journal of Clinical Investigation
  • Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth, 2024, Nature Communications
  • Genetic analysis of multiple myeloma identifies cytogenetic alterations implicated in disease complexity and progression, 2021, Cancers
  • CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation, 2022, Journal of Clinical Investigation

John D. Shaughnessy has received recognition as a Fellow of the American Statistical Association (ASA) in 2019.

Best Publications

  • The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

    Erming Tian;Fenghuang Zhan;Ronald Walker;Erik Rasmussen

  • The molecular classification of multiple myeloma

    Fenghuang Zhan;Yongsheng Huang;Yongsheng Huang;Simona Colla;Simona Colla;James P. Stewart;James P. Stewart

  • The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

    Christina M. Annunziata;R. Eric Davis;Yulia Demchenko;William Bellamy

  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    John D. Shaughnessy;Fenghuang Zhan;Bart E. Burington;Yongsheng Huang

  • Genetics and Cytogenetics of Multiple Myeloma A Workshop Report

    Rafael Fonseca;Bart Barlogie;Regis Bataille;Christian Bastard

  • Absence epilepsy in tottering mutant mice is associated with calcium channel defects

    Colin F Fletcher;Cathleen M Lutz;T.Norene O'Sullivan;John D Shaughnessy

  • Thalidomide and hematopoietic-cell transplantation for multiple myeloma

    Bart Barlogie;Guido Tricot;Elias Anaissie;John Shaughnessy

  • Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

    P. Leif Bergsagel;W. Michael Kuehl;Fenghuang Zhan;Jeffrey Sawyer

  • Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

    Fenghuang Zhan;Johanna S. Hardin;Bob Kordsmeier;Klaus Bumm

  • Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.

    Bart Barlogie;Raman Desikan;Raman Desikan;Paul Eddlemon;Paul Eddlemon;Trey Spencer;Trey Spencer

  • Treatment of multiple myeloma

    Bart Barlogie;John D Shaughnessy;Guido Tricot;Joth Jacobson

  • CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

    Eric D. Hsi;Roxanne Steinle;Balaji Balasa;Susann Szmania

  • Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia

    Takuro Nakamura;David A. Largaespada;Maxwell P. Lee;Laura A. Johnson

  • Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

    Ichiro Hanamura;James P. Stewart;James P. Stewart;Yongsheng Huang;Yongsheng Huang;Fenghuang Zhan;Fenghuang Zhan

  • F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

    Twyla B. Bartel;Jeff Haessler;Tracy L. Y. Brown;John D. Shaughnessy

  • High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.

    Daniel R. Carrasco;Giovanni Tonon;Yongsheng Huang;Yunyu Zhang

  • Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.

    Shmuel Yaccoby;Wen Ling;Fenghuang Zhan;Ronald Walker

  • The role of Dickkopf-1 in bone development, homeostasis, and disease

    Joseph J. Pinzone;Brett M. Hall;Nanda K. Thudi;Martin Vonau

Frequent Co-Authors

Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
John Crowley
John Crowley Washington University in St. Louis
Elias Anaissie
Elias Anaissie University of Cincinnati
Guido Tricot
Guido Tricot University of Iowa
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center
Thierry Rème
Thierry Rème Grenoble Alpes University
Madhav V. Dhodapkar
Madhav V. Dhodapkar Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online medical and nursing degrees offers flexibility and a range of career opportunities for students and professionals alike. For those seeking cost-effective options, there are affordable nursing programs online that can help launch or advance careers in healthcare without the need for on-campus attendance.

Advancement in nursing often requires higher qualifications. Earning an online phd in nursing opens the door to roles in research, education, and leadership, while also offering flexible learning formats for working professionals.

Registered Nurses looking to elevate their credentials can explore the average cost of rn to bsn programs to find budget-friendly pathways toward a BSN degree. This can lead to more opportunities and higher salaries in the job market.

For individuals from non-nursing backgrounds, direct entry nurse practitioner programs for non-nurses online provide accelerated routes into advanced nursing careers. These programs are ideal for those seeking a fast transition into the healthcare field.

Best Scientists Citing John D. Shaughnessy

Trending Scientists

Recently Published Articles